Skip to main content
Top
Published in: Surgical Endoscopy 4/2020

01-04-2020 | Endoscopy

The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6

Authors: Er-Hsiang Yang, Chung-Tai Wu, Hsin-Yu Kuo, Wei-Ying Chen, Bor-Shyang Sheu, Hsiu-Chi Cheng

Published in: Surgical Endoscopy | Issue 4/2020

Login to get access

Abstract

Background

The Forrest classification is widely applied to guide endoscopic hemostasis for peptic ulcer bleeding. Accordingly, practice guidelines suggest medical treatment only for ulcer with a Forrest IIc lesion because it has low rebleeding risk even without endoscopic therapy, ranging from 0 to 13%. However, the risk ranges widely and it is unclear who is at risk of rebleeding with such a lesion. This study assessed whether the Rockall score, which evaluates patients holistically, could indicate the risk of recurrent bleeding among patients with a Forrest IIc lesion at the second-look endoscopy.

Methods

Patients who had peptic ulcer bleeding with Ia-IIb lesions received endoscopic hemostasis at the primary endoscopy, and they were enrolled if their Ia-IIb lesions had been fading to IIc at the second-look endoscopy after 48- to 72-h intravenous proton pump inhibitor (PPI) infusion. Primary outcomes were rebleeding during the 4th–14th day and 4th–28th day after the first bleeding episode.

Results

The prospective cohort study enrolled 140 patients, who were divided into a Rockall scores ≥ 6 group or a Rockall scores < 6 group. The rebleeding rates in the Rockall scores ≥ 6 group and the Rockall scores < 6 group during the 4th–14th day and the 4th–28th day were 13/70 (18.6%) versus 2/70 (2.9%), p = 0.003 and 17/70 (24.3%) versus 3/70 (4.3%), p = 0.001, respectively, based on an intention-to-treat analysis and 5/62 (8.1%) versus 0/68 (0%), p = 0.023 and 6/59 (10.2%) versus 0/67 (0%), p = 0.009, respectively, based on a per-protocol analysis. The Kaplan–Meier curves showed that the Rockall scores ≥ 6 group had a significantly lower cumulative rebleeding-free proportion than the Rockall scores < 6 group (p = 0.01).

Conclusions

Combined Rockall scores ≥ 6 on arrival with a Forrest IIc lesion at the second-look endoscopy can identify patients at risk of recurrent peptic ulcer bleeding following initial endoscopic and intravenous PPI treatment.
Trial registration Trial registration identifier: NCT01591083
Literature
1.
go back to reference Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE (1995) Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 90:568–573PubMed Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE (1995) Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 90:568–573PubMed
2.
go back to reference Forrest JA, Finlayson ND, Sherman DJ (1974) Endoscopy in gastrointestinal bleeding. Lancet 2:394–397CrossRefPubMed Forrest JA, Finlayson ND, Sherman DJ (1974) Endoscopy in gastrointestinal bleeding. Lancet 2:394–397CrossRefPubMed
4.
go back to reference Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS (2003) Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology 50:2270–2273PubMed Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS (2003) Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology 50:2270–2273PubMed
5.
go back to reference Cheng HC, Kao AW, Chuang CH, Sheu BS (2005) The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci 50:1194–1201CrossRefPubMed Cheng HC, Kao AW, Chuang CH, Sheu BS (2005) The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci 50:1194–1201CrossRefPubMed
6.
go back to reference Tseng GY, Fang CT, Lin HJ, Yang HB, Tseng GC, Wang PC, Liao PC, Cheng YT, Huang CH (2009) Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study. Aliment Pharmacol Ther 30:406–413CrossRefPubMed Tseng GY, Fang CT, Lin HJ, Yang HB, Tseng GC, Wang PC, Liao PC, Cheng YT, Huang CH (2009) Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study. Aliment Pharmacol Ther 30:406–413CrossRefPubMed
8.
go back to reference Weiler H, Weiler C, Gerok W (1990) Gastric mucosal prostsgladin E2 levels in cirrhosis and portal hypertension. J Hepatol 11:58–64CrossRefPubMed Weiler H, Weiler C, Gerok W (1990) Gastric mucosal prostsgladin E2 levels in cirrhosis and portal hypertension. J Hepatol 11:58–64CrossRefPubMed
9.
go back to reference Bresalier R (1991) The clinical significance and pathophysiology of stress-related gastric mucosal hemorrhage. J Clin Gastroenterol 13(Suppl 2):S35–S43PubMed Bresalier R (1991) The clinical significance and pathophysiology of stress-related gastric mucosal hemorrhage. J Clin Gastroenterol 13(Suppl 2):S35–S43PubMed
10.
go back to reference Cheng HC, Yang HB, Chang WL, Yeh YC, Tsai YC, Sheu BS (2011) Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding. BMC Gastroenterol 11:24CrossRefPubMedPubMedCentral Cheng HC, Yang HB, Chang WL, Yeh YC, Tsai YC, Sheu BS (2011) Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding. BMC Gastroenterol 11:24CrossRefPubMedPubMedCentral
11.
go back to reference Cheng HC, Wu CT, Chang WL, Cheng WC, Chen WY, Sheu BS (2014) Double oral esomeprazole after three-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients—a randomized controlled study. Gut 63:1864–1872CrossRefPubMed Cheng HC, Wu CT, Chang WL, Cheng WC, Chen WY, Sheu BS (2014) Double oral esomeprazole after three-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients—a randomized controlled study. Gut 63:1864–1872CrossRefPubMed
12.
go back to reference Yang EH, Cheng HC, Wu CT, Chen WY, Lin MY, Sheu BS (2018) Peptic ulcer bleeding patients with Rockall Scores ≥ 6 are at risk of long-term ulcer rebleeding: a 3.5-year prospective longitudinal study. J Gastroenterol Hepatol 33:156–163CrossRefPubMed Yang EH, Cheng HC, Wu CT, Chen WY, Lin MY, Sheu BS (2018) Peptic ulcer bleeding patients with Rockall Scores ≥ 6 are at risk of long-term ulcer rebleeding: a 3.5-year prospective longitudinal study. J Gastroenterol Hepatol 33:156–163CrossRefPubMed
13.
go back to reference Cheng HC, Wu CT, Chen WY, Yang EH, Chen PJ, Sheu BS (2016) Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion. Endosc Int Open 04:E255–E262CrossRef Cheng HC, Wu CT, Chen WY, Yang EH, Chen PJ, Sheu BS (2016) Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion. Endosc Int Open 04:E255–E262CrossRef
14.
go back to reference Cheng HC, Yang EH, Wu CT, Wang WL, Chen PJ, Lin MY, Sheu BS (2018) Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use. J Formos Med Assoc 117:316–325CrossRefPubMed Cheng HC, Yang EH, Wu CT, Wang WL, Chen PJ, Lin MY, Sheu BS (2018) Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use. J Formos Med Assoc 117:316–325CrossRefPubMed
15.
go back to reference Laine L, McQuaid KR (2009) Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 7:33–47CrossRefPubMed Laine L, McQuaid KR (2009) Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 7:33–47CrossRefPubMed
16.
go back to reference Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M (2009) Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 69:786–799CrossRefPubMed Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M (2009) Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 69:786–799CrossRefPubMed
17.
go back to reference Sheu BS, Wu CY, Wu MS, Chiu CT, Lin CC, Hsu PI, Cheng HC, Lee TY, Yang HP, Lin JT (2014) Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance. Biomed Res Int 2014:563707PubMedPubMedCentral Sheu BS, Wu CY, Wu MS, Chiu CT, Lin CC, Hsu PI, Cheng HC, Lee TY, Yang HP, Lin JT (2014) Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance. Biomed Res Int 2014:563707PubMedPubMedCentral
18.
go back to reference Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, Rotondano G, Hucl T, Dinis-Ribeiro M, Marmo R, Racz I, Arezzo A, Hoffmann RT, Lesur G, de Franchis R, Aabakken L, Veitch A, Radaelli F, Salgueiro P, Cardoso R, Maia L, Zullo A, Cipolletta L, Hassan C (2015) Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 47:a1–a46CrossRefPubMed Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, Rotondano G, Hucl T, Dinis-Ribeiro M, Marmo R, Racz I, Arezzo A, Hoffmann RT, Lesur G, de Franchis R, Aabakken L, Veitch A, Radaelli F, Salgueiro P, Cardoso R, Maia L, Zullo A, Cipolletta L, Hassan C (2015) Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 47:a1–a46CrossRefPubMed
19.
go back to reference Sung JJ, Chan FK, Chen M, Ching JY, Ho KY, Kachintorn U, Kim N, Lau JY, Menon J, Rani AA, Reddy N, Sollano J, Sugano K, Tsoi KK, Wu CY, Yeomans N, Vakil N, Goh KL (2011) Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding. Gut 60:1170–1177CrossRefPubMed Sung JJ, Chan FK, Chen M, Ching JY, Ho KY, Kachintorn U, Kim N, Lau JY, Menon J, Rani AA, Reddy N, Sollano J, Sugano K, Tsoi KK, Wu CY, Yeomans N, Vakil N, Goh KL (2011) Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding. Gut 60:1170–1177CrossRefPubMed
20.
go back to reference Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS (2009) Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastrointest Endosc 70:433–439CrossRefPubMed Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS (2009) Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastrointest Endosc 70:433–439CrossRefPubMed
21.
go back to reference Lau JY, Leung WK, Wu JC, Chan FK, Wong VW, Chiu PW, Lee VW, Lee KK, Cheung FK, Siu P, Ng EK, Sung JJ (2007) Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356:1631–1640CrossRefPubMed Lau JY, Leung WK, Wu JC, Chan FK, Wong VW, Chiu PW, Lee VW, Lee KK, Cheung FK, Siu P, Ng EK, Sung JJ (2007) Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356:1631–1640CrossRefPubMed
22.
go back to reference Zatorski H (2017) Pathophysiology and risk factors in peptic ulcer disease. In: Fichna J (ed) Introduction to gastrointestinal diseases, vol 2. Springer. Cham, Switzerland, pp 7–20CrossRef Zatorski H (2017) Pathophysiology and risk factors in peptic ulcer disease. In: Fichna J (ed) Introduction to gastrointestinal diseases, vol 2. Springer. Cham, Switzerland, pp 7–20CrossRef
23.
go back to reference Allen A, Flemström G (2005) Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Phys Cell Physiol 288:C1–C19CrossRef Allen A, Flemström G (2005) Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Phys Cell Physiol 288:C1–C19CrossRef
24.
go back to reference Laine L, Takeuchi K, Tarnawski A (2008) Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135:41–60CrossRefPubMed Laine L, Takeuchi K, Tarnawski A (2008) Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135:41–60CrossRefPubMed
25.
go back to reference Taylor SD, Soudah HC, Chey WY, Scheiman JM (1994) Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins. Gastroenterology 107:1680–1685CrossRefPubMed Taylor SD, Soudah HC, Chey WY, Scheiman JM (1994) Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins. Gastroenterology 107:1680–1685CrossRefPubMed
26.
go back to reference Flemström G, Garner A (1982) Gastroduodenal HCO3− transport: characteristics and proposed role in acidity regulation and mucosal protection. Am J Physiol 242:G183–G193PubMed Flemström G, Garner A (1982) Gastroduodenal HCO3 transport: characteristics and proposed role in acidity regulation and mucosal protection. Am J Physiol 242:G183–G193PubMed
27.
go back to reference Sørbye H, Svanes K (1994) The role of blood flow in gastric mucosal defence, damage and healing. Dig Dis 12:305–317CrossRefPubMed Sørbye H, Svanes K (1994) The role of blood flow in gastric mucosal defence, damage and healing. Dig Dis 12:305–317CrossRefPubMed
28.
go back to reference Selling JA, Hogan DL, Aly A, Koss MA, Isenberg JI (1987) Indomethacin inhibits duodenal mucosal bicarbonate secretion and endogenous prostaglandin E2 output in human subjects. Ann Intern Med 106:368–371CrossRefPubMed Selling JA, Hogan DL, Aly A, Koss MA, Isenberg JI (1987) Indomethacin inhibits duodenal mucosal bicarbonate secretion and endogenous prostaglandin E2 output in human subjects. Ann Intern Med 106:368–371CrossRefPubMed
29.
go back to reference Gralnek IM, Barkun AN, Bardou M (2008) Management of acute bleeding from a peptic ulcer. N Engl J Med 359:928–937CrossRefPubMed Gralnek IM, Barkun AN, Bardou M (2008) Management of acute bleeding from a peptic ulcer. N Engl J Med 359:928–937CrossRefPubMed
30.
go back to reference Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P (2010) International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 152:101–113CrossRefPubMed Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P (2010) International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 152:101–113CrossRefPubMed
31.
go back to reference Laine L, Jensen DM (2012) Management of patients with ulcer bleeding. Am J Gastroenterol 107:345–360CrossRefPubMed Laine L, Jensen DM (2012) Management of patients with ulcer bleeding. Am J Gastroenterol 107:345–360CrossRefPubMed
Metadata
Title
The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6
Authors
Er-Hsiang Yang
Chung-Tai Wu
Hsin-Yu Kuo
Wei-Ying Chen
Bor-Shyang Sheu
Hsiu-Chi Cheng
Publication date
01-04-2020
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 4/2020
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-06919-3

Other articles of this Issue 4/2020

Surgical Endoscopy 4/2020 Go to the issue